The PI3K-AKT-mTOR pathway interacts with multiple cellular cascades, further promoting PCa progression and aggression, and drugs targeting this pathway are employed in clinical settings (Shorning et al., 2020). The gene discussed is MTOR; the disease is posterior cortical atrophy.